Platelet aggregation platelet-rich plasma whole blood patients myeloproliferative disorders vitro platelet aggregation platelet-rich plasma PRP whole blood WB patients idiopathic myelofibrosis essential thrombocytosis polycythemia vera chronic myelogenous leukemia PRP subjects normal reduced platelet aggregation whereas WB majority patients increased platelet function Spontaneous platelet aggregation SPA WB PRP SPA WB vitro addition aspirin apyrase SPA dependent high platelet count samples normal platelet content variance subjects reactive thrombocytosis SPA samples high platelet concentration Platelets patients idiopathic myelofibrosis tendency SPA 